DNA X, Inc. (SONM) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 3 Buy, 1 Hold.
Analysts estimate Earnings Per Share (EPS) of $-54.36 and revenue of $0.06B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-7.13 vs est $-54.36 (beat +86.9%). Analyst accuracy: 0%.
SONM Analyst Ratings
Buy
Based on 4 analysts giving stock ratings to DNA X, Inc. in the past 3 months
EPS Estimates — SONM
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual –$7.13
vs Est –$54.36
▲ 662.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — SONM
92%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024
Actual $0.058B
vs Est $0.063B
▼ 7.9% off
Revenue Trend
Analysts expect stable revenue going forward.
